OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Review on the Therapeutic Role of TKIs in Case of CML in Combination With Epigenetic Drugs
Mohd Amir, Saleem Javed
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 17
Mohd Amir, Saleem Javed
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 17
Showing 17 citing articles:
The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia
Mohamed El‐Tanani, Hamdi Nsairat, Ismail Matalka, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155161-155161
Open Access | Times Cited: 15
Mohamed El‐Tanani, Hamdi Nsairat, Ismail Matalka, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155161-155161
Open Access | Times Cited: 15
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent
Alessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.
Cell Biology International (2025)
Open Access | Times Cited: 1
Alessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.
Cell Biology International (2025)
Open Access | Times Cited: 1
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
Antonio Matrone, Carla Gambale, Alessandro Prete, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
Antonio Matrone, Carla Gambale, Alessandro Prete, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer: Current Use and Future Prospects
Henry Dickerson, Ahmad I Diab, Othman Al Musaimi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10008-10008
Open Access | Times Cited: 8
Henry Dickerson, Ahmad I Diab, Othman Al Musaimi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10008-10008
Open Access | Times Cited: 8
Exploring the interaction of tepotinib with calf thymus DNA using molecular dynamics simulation and multispectroscopic techniques
Mohd Amir, M. A. Qureshi, Ashma Khan, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2023) Vol. 308, pp. 123678-123678
Closed Access | Times Cited: 10
Mohd Amir, M. A. Qureshi, Ashma Khan, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2023) Vol. 308, pp. 123678-123678
Closed Access | Times Cited: 10
The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
Fangyi Yao, Fangmin Zhong, Junyao Jiang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 993-1008
Open Access | Times Cited: 7
Fangyi Yao, Fangmin Zhong, Junyao Jiang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 993-1008
Open Access | Times Cited: 7
Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1
Shan Gao, Tingting Guo, Shuyu Luo, et al.
Biomolecules & Therapeutics (2022) Vol. 30, Iss. 6, pp. 553-561
Open Access | Times Cited: 8
Shan Gao, Tingting Guo, Shuyu Luo, et al.
Biomolecules & Therapeutics (2022) Vol. 30, Iss. 6, pp. 553-561
Open Access | Times Cited: 8
Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management
Amir Askarinejad, Azin Alizadehasl, Amir Ghaffari Jolfayi, et al.
Cardio-Oncology (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Amir Askarinejad, Azin Alizadehasl, Amir Ghaffari Jolfayi, et al.
Cardio-Oncology (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?
Alexander Yakobson, Ala Eddin Neime, Omar Abu Saleh, et al.
Clinics and Practice (2023) Vol. 13, Iss. 5, pp. 1082-1089
Open Access | Times Cited: 2
Alexander Yakobson, Ala Eddin Neime, Omar Abu Saleh, et al.
Clinics and Practice (2023) Vol. 13, Iss. 5, pp. 1082-1089
Open Access | Times Cited: 2
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking
Hongxing Li, Yuan-Xue Jing, Yi-Hong Chai, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 16, pp. 1838-1847
Closed Access | Times Cited: 1
Hongxing Li, Yuan-Xue Jing, Yi-Hong Chai, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 16, pp. 1838-1847
Closed Access | Times Cited: 1
Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
Lingyan Zhou, Xiao-Cheng Yin
PubMed (2024) Vol. 49, Iss. 1, pp. 122-127
Closed Access
Lingyan Zhou, Xiao-Cheng Yin
PubMed (2024) Vol. 49, Iss. 1, pp. 122-127
Closed Access
AMPK activation; a potential strategy to mitigate TKI-induced cardiovascular toxicity
Naser Safaie, Gholamreza Idari, Diba Ghasemi, et al.
Archives of Physiology and Biochemistry (2024), pp. 1-13
Closed Access
Naser Safaie, Gholamreza Idari, Diba Ghasemi, et al.
Archives of Physiology and Biochemistry (2024), pp. 1-13
Closed Access
Small Molecule Inhibitors: Precision Tools Targeting Oncogenic Pathways for Therapeutic Intervention in Cancer
Subhayan Chattopadhyay, Danyal Reyaz, Shriya Pattabiram, et al.
(2024), pp. 231-252
Closed Access
Subhayan Chattopadhyay, Danyal Reyaz, Shriya Pattabiram, et al.
(2024), pp. 231-252
Closed Access
Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking
Yihong Chai, Feng Chen, Zijian Li, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 384-395
Closed Access | Times Cited: 1
Yihong Chai, Feng Chen, Zijian Li, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 384-395
Closed Access | Times Cited: 1
Advances in the Treatment of Chronic Myeloid Leukemia
Romeo-Gabriel Mihăilă
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 1-17
Closed Access
Romeo-Gabriel Mihăilă
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 1-17
Closed Access
A Discussion of Chronic Myeloid Leukemia
Leqi Shen
Journal of Innovations in Medical Research (2023) Vol. 2, Iss. 10, pp. 11-22
Open Access
Leqi Shen
Journal of Innovations in Medical Research (2023) Vol. 2, Iss. 10, pp. 11-22
Open Access
KIAA1429 regulates the expression of RAB27B in a m6A YTHDF1 axis-dependent manner and promotes the progression of chronic myeloid leukemia, serving as a potential therapeutic target
Fangyi Yao, Fangmin Zhong, Junyao Jiang, et al.
Research Square (Research Square) (2022)
Open Access
Fangyi Yao, Fangmin Zhong, Junyao Jiang, et al.
Research Square (Research Square) (2022)
Open Access
